摘要
为了探讨温寒化瘀、健脾降胃、解毒抗癌的中药在治疗中晚期胃癌中的作用。将102例中、晚期胃癌患者分为两组,单纯中药组以温寒化瘀、健脾降胃、解毒抗癌法治疗69例,中药加化疗组治疗33例,两组进行比较。结果:单纯中药组中50例经随访1、3、5年生存率分别为84％、56.4％、45.4％,中位生存期为2.45年,而中药加化疗组经随访30例中,1、3、5年生存率分别为76.7％、53.3％、43.3％,中位生存期为1.73年。临床单纯中药组优于中药加化疗组,但无统计学意义。表明中药能改善症状,提高疗效,增加机体免疫功能,同时能减轻化疗病人的毒副反应、防治术后复发、降低转移率、延长远期生存率、改善生活质量。
Drugs for expelling pathogenic cold to resolving stasis, descending the stomach - fire by invigorating the spleen and treating cancer by detoxifying were used in the controlled clinical trial. The one - year, three - year and five - year survival rates in the treatment group (N = 69) were 84%, 56.4% and 45. 4%, respectively (median, 2. 45 years). In comparison with the control group with TCM drugs plus chemotherapy (N = 30) it was 76. 7%, 53. 3% and 43. 3%, (median, 1. 73 years) respectively. Clinical observation favored the treatment group in improving the symptoms, prolong the survival period, less toxic, less recurrence and metastasis, however, the difference was not significant in statistical analysis.
出处
《中医杂志》
CSCD
北大核心
2000年第8期483-484,共2页
Journal of Traditional Chinese Medicine
